According to Capcom’s most recent financial release, the Resident Evil series has now sold more than 200 million units since the original title launched in 1996.
The milestone underscores the enduring market strength of the survival-horror brand across multiple generations of hardware.
Capcom’s report lists precise lifetime figures for recent and legacy entries.
The newest mainline entry, Resident Evil Requiem, has recorded 6.91 million units sold to date, while long-standing best-sellers remain near the top of the franchise ranking: Resident Evil 5 has sold in excess of 19 million units, and the Resident Evil 2 Remake has surpassed 18 million units.
These verified figures were published directly by Capcom in its financial materials.
In plain terms, Capcom’s release states that the Resident Evil franchise has reached over 200 million lifetime sales — a benchmark that highlights the series’ broad platform presence.
Resident Evil games have been distributed across PlayStation, Xbox, PC and Nintendo platforms, including ports and cloud releases that have brought several entries to the Nintendo Switch and listings on the eShop.
Capcom’s financial update also provided consolidated lifetime sales figures for other flagship franchises.
Monster Hunter sits at 127 million units, Street Fighter at 59 million, and Mega Man at 44 million.
These totals reflect Capcom’s performance across new releases, remasters and long-running catalogue sales.
Industry coverage has noted ongoing commentary and speculation about future entries and remakes in the Resident Evil line.
Capcom’s official release did not announce specific development plans; it focused on the confirmed sales metrics and portfolio performance.
For readers tracking platform-specific availability, many Resident Evil titles and spin-offs have appeared on Nintendo hardware over the years, and select games are offered via the Nintendo eShop or as cloud versions on Nintendo Switch.
Capcom’s financial disclosures provide a clear, audited snapshot of how its major IPs are performing commercially as the company moves forward into the next fiscal periods.